1. Home
  2. COHN vs IMNN Comparison

COHN vs IMNN Comparison

Compare COHN & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COHN
  • IMNN
  • Stock Information
  • Founded
  • COHN 1999
  • IMNN 1982
  • Country
  • COHN United States
  • IMNN United States
  • Employees
  • COHN N/A
  • IMNN N/A
  • Industry
  • COHN Investment Bankers/Brokers/Service
  • IMNN Biotechnology: Pharmaceutical Preparations
  • Sector
  • COHN Finance
  • IMNN Health Care
  • Exchange
  • COHN Nasdaq
  • IMNN Nasdaq
  • Market Cap
  • COHN 19.3M
  • IMNN 12.2M
  • IPO Year
  • COHN N/A
  • IMNN 1985
  • Fundamental
  • Price
  • COHN $10.54
  • IMNN $0.83
  • Analyst Decision
  • COHN
  • IMNN Strong Buy
  • Analyst Count
  • COHN 0
  • IMNN 2
  • Target Price
  • COHN N/A
  • IMNN $20.50
  • AVG Volume (30 Days)
  • COHN 7.7K
  • IMNN 355.1K
  • Earning Date
  • COHN 11-04-2024
  • IMNN 11-07-2024
  • Dividend Yield
  • COHN 9.79%
  • IMNN N/A
  • EPS Growth
  • COHN N/A
  • IMNN N/A
  • EPS
  • COHN 2.35
  • IMNN N/A
  • Revenue
  • COHN $89,555,000.00
  • IMNN N/A
  • Revenue This Year
  • COHN N/A
  • IMNN N/A
  • Revenue Next Year
  • COHN N/A
  • IMNN N/A
  • P/E Ratio
  • COHN $4.35
  • IMNN N/A
  • Revenue Growth
  • COHN 63.18
  • IMNN N/A
  • 52 Week Low
  • COHN $6.10
  • IMNN $0.48
  • 52 Week High
  • COHN $12.82
  • IMNN $3.65
  • Technical
  • Relative Strength Index (RSI)
  • COHN 54.50
  • IMNN 47.27
  • Support Level
  • COHN $10.06
  • IMNN $0.80
  • Resistance Level
  • COHN $11.05
  • IMNN $0.88
  • Average True Range (ATR)
  • COHN 0.48
  • IMNN 0.05
  • MACD
  • COHN -0.08
  • IMNN 0.00
  • Stochastic Oscillator
  • COHN 43.20
  • IMNN 25.00

About COHN Cohen & Company Inc.

Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.

About IMNN Imunon Inc.

Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.

Share on Social Networks: